BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 30401576)

  • 1. An international perspective on hospitalized patients with viral community-acquired pneumonia.
    Radovanovic D; Sotgiu G; Jankovic M; Mahesh PA; Marcos PJ; Abdalla MI; Di Pasquale MF; Gramegna A; Terraneo S; Blasi F; Santus P; Aliberti S; Reyes LF; Restrepo MI;
    Eur J Intern Med; 2019 Feb; 60():54-70. PubMed ID: 30401576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of influenza A 2009 (H1N1) pneumonia is underestimated by routine prediction rules. Results from a prospective, population-based study.
    Bjarnason A; Thorleifsdottir G; Löve A; Gudnason JF; Asgeirsson H; Hallgrimsson KL; Kristjansdottir BS; Haraldsson G; Baldursson O; Kristinsson KG; Gottfredsson M
    PLoS One; 2012; 7(10):e46816. PubMed ID: 23071646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza Testing and Treatment Among Patients Hospitalized With Community-Acquired Pneumonia.
    Deshpande A; Klompas M; Yu PC; Imrey PB; Pallotta AM; Higgins T; Haessler S; Zilberberg MD; Lindenauer PK; Rothberg MB
    Chest; 2022 Sep; 162(3):543-555. PubMed ID: 35134384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical features and outcomes of hospitalized adult patients with novel influenza A (H1N1) pneumonia and other pneumonia.
    Sohn CH; Ryoo SM; Yoon JY; Seo DW; Lim KS; Kim SH; Hong SB; Lim CM; Koh YS; Kim WY
    Acad Emerg Med; 2013 Jan; 20(1):46-53. PubMed ID: 23570478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective.
    Gramegna A; Sotgiu G; Di Pasquale M; Radovanovic D; Terraneo S; Reyes LF; Vendrell E; Neves J; Menzella F; Blasi F; Aliberti S; Restrepo MI;
    BMC Infect Dis; 2018 Dec; 18(1):677. PubMed ID: 30563504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza A-associated severe pneumonia in hospitalized patients: Risk factors and NAI treatments.
    Zou Q; Zheng S; Wang X; Liu S; Bao J; Yu F; Wu W; Wang X; Shen B; Zhou T; Zhao Z; Wang Y; Chen R; Wang W; Ma J; Li Y; Wu X; Shen W; Xie F; Vijaykrishna D; Chen Y
    Int J Infect Dis; 2020 Mar; 92():208-213. PubMed ID: 31978583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAUSATIVE AGENTS OF SEVERE COMMUNITY ACQUIRED VIRAL PNEUMONIA AMONG CHILDREN IN EASTERN THAILAND.
    Pratheepamornkull T; Ratanakorn W; Samransamruajkit R; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):650-6. PubMed ID: 26867384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the role of respiratory viruses in community-acquired pneumonia?: What is the best therapy for influenza and other viral causes of community-acquired pneumonia?
    Pavia AT
    Infect Dis Clin North Am; 2013 Mar; 27(1):157-75. PubMed ID: 23398872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiology of community-acquired pneumonia in hospitalized patients in chile: the increasing prevalence of respiratory viruses among classic pathogens.
    Díaz A; Barria P; Niederman M; Restrepo MI; Dreyse J; Fuentes G; Couble B; Saldias F
    Chest; 2007 Mar; 131(3):779-787. PubMed ID: 17356093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of early oseltamivir treatment for hospitalized adult patients with community-acquired influenza pneumonia.
    Kositpantawong N; Surasombatpattana S; Siripaitoon P; Kanchanasuwan S; Hortiwakul T; Charernmak B; Nwabor OF; Chusri S
    PLoS One; 2021; 16(12):e0261411. PubMed ID: 34910777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of respiratory viruses among patients admitted to 26 Intensive Care Units in seven consecutive winter-spring seasons (2009-2016) in Northern Italy.
    Piralla A; Mariani B; Rovida F; Baldanti F
    J Clin Virol; 2017 Jul; 92():48-51. PubMed ID: 28527970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection.
    Viasus D; Paño-Pardo JR; Pachón J; Riera M; López-Medrano F; Payeras A; Fariñas MC; Moreno A; Rodríguez-Baño J; Oteo JA; Ortega L; Torre-Cisneros J; Segura F; Carratalà J;
    Chest; 2011 Oct; 140(4):1025-1032. PubMed ID: 21415133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial.
    Huijts SM; Coenjaerts FEJ; Bolkenbaas M; van Werkhoven CH; Grobbee DE; Bonten MJM;
    Clin Microbiol Infect; 2018 Jul; 24(7):764-770. PubMed ID: 29050992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resurgence of common respiratory viruses in patients with community-acquired pneumonia (CAP)-A prospective multicenter study.
    Dähne T; Bauer W; Essig A; Schaaf B; Barten-Neiner G; Spinner CD; Pletz MW; Rohde G; Rupp J; Witzenrath M; Panning M;
    J Clin Virol; 2024 Aug; 173():105694. PubMed ID: 38781632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of respiratory viruses in patients with community-acquired pneumonia admitted to the intensive care unit: results from the Severe Influenza Pneumonia Surveillance (SIPS) project.
    Wiemken T; Peyrani P; Bryant K; Kelley RR; Summersgill J; Arnold F; Carrico R; McKinney WP; Jonsson C; Carrico K; Ramirez J
    Eur J Clin Microbiol Infect Dis; 2013 May; 32(5):705-10. PubMed ID: 23274861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of severe human metapneumovirus-associated community-acquired pneumonia in adults.
    Choi SH; Hong SB; Huh JW; Jung J; Kim MJ; Chong YP; Kim SH; Sung H; Koo HJ; Do KH; Lee SO; Lim CM; Kim YS; Woo JH; Koh Y
    J Clin Virol; 2019 Aug; 117():1-4. PubMed ID: 31128379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of empirical oseltamivir discontinuation in hospitalized patients with community-acquired pneumonia after confirmed negative for influenza.
    Alghanem AF; Aldhahri FA; Althemery AU
    Saudi Med J; 2021 Oct; 42(10):1072-1077. PubMed ID: 34611001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011.
    Wang B; Taylor J; Ratnamohan M; McPhie K; Kesson A; Dixit R; Booy R; Hurt A; Saksena N; Dwyer DE
    Euro Surveill; 2012 Jul; 17(27):. PubMed ID: 22790606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with influenza A/H1N1v- associated pneumonia: the perspective of a tertiary care hospital in Switzerland.
    Bertisch B; Vernazza P; Boggian K
    Swiss Med Wkly; 2010; 140():w13069. PubMed ID: 20640947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral community acquired pneumonia at the emergency department: Report from the pre COVID-19 age.
    Spagnolello O; Pierangeli A; Cedrone MC; Di Biagio V; Gentile M; Leonardi A; Valeriano C; Innocenti GP; Santinelli L; Borrazzo C; Russo A; Oliveto G; Viscido A; Ciccozzi M; Bertazzoni G; d'Ettorre G; Ceccarelli G
    J Med Virol; 2021 Jul; 93(7):4399-4404. PubMed ID: 33783850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.